Table 2.
Progestogens used for HRT in China and the United States. (values are based on the CFDA and FDA databases)
Composition | dosage forms | Available dosages |
---|---|---|
Progestogen-only | ||
Progesterone | Soft Capsules | 100, 200 mg |
vaginal gel | 4%, 8% gel | |
Medroxyprogesterone Acetate | Oral tablet | 2.5, 5, 10, 100, 500 mg |
Norethisterone (norethindrone)b | Oral tablet | 0.35 mg |
Levonorgestrel | Implants, Tablets, Intrauterine device | 1.5 mg, 36 mg, 52 mg |
Norgestrel | Tablets | 0.075 mg, 3 mg |
Dydrogesteronea | Tablets | 10 mg |
Combined with estrogen | ||
estradiol + norethindrone acetate | Film, Extended release /Transdermal | 50 μg/24 h; 0.14 mg/24 h; 50 μg/24 h; 0.25 mg/24 h; 10 mg E + 30 mg P |
Tablets/Oral | 1 mg/0.5 mg; 0.5 mg/0.1 mg | |
estradiol + drospirenone | Tablets/Oral | 0.5 mg/0.25 mg; 1 mg/0.5 mg; 1 mg/2 mg |
estradiol + dydrogesteronea | Tablets/Oral | 1 mg/10 mg |
estradiol + cyproterone acetatea | Tablets/Oral | 2 mg/1 mg |
conjugated equine estrogens + medroxyprogesterone acetateb | Tablets/Oral | 0.3 mg/1.5 mg; 0.45 mg/1.5 mg; 0.625 mg/2.5 mg; 0.625 mg/5 mg |
ethinyl estradiol + norethindrone acetateb | Tablets/Oral | 5 μg/1 mg; 25 μg/0.5 mg |
Products not marked are available in both China and the United States
aAvailable only in China
bAvailable only in the United States